Australia's Latrobe Magnesium surges after outlining US plant plans
Australia's Latrobe Magnesium surges after outlining US plant plans Sept 15 (Reuters) - Australia's Latrobe Magnesium LMG.AX unveiled plans on Tuesday to build a magnesium plant in the U.S. with an estimated capital cost of $1.1 billion to $1.5 billion to tap into the North American market, sending its shares up 80% in intraday trade.
Here are some more details:
Shares of the Sydney-based company were last up 50% at 0420 GMT, heading for their biggest one-day gain in nearly five years.
The magnesium producer said the project will be the first commercial-scale magnesium-producing plant in North America, delivering for the U.S. defence, which faces a supply shortage.
The company said it aims to build a 50,000-metric-ton-per-annum (ktpa) plant, which can be expanded to 100 ktpa.
First production is targeted in 2030, the firm said.
(Reporting by Aamir Shaik Khalid in Bengaluru; Editing by Subhranshu Sahu)
((Aamir.SheikKhalid@thomsonreuters.com;))
Recent news on Latrobe Magnesium
See all newsBrief: Latrobe Magnesium Signs LOI For Land Package In South Carolina
Brief: Latrobe Magnesium To Raise A$8.5 Million In New Equity Capital
Australia's Latrobe Magnesium falls on discounted fund raising
Brief: Latrobe Magnesium Requests Trading Halt
Brief: Latrobe Magnesium Gets $15M Non-Binding Letter Of Support